Benutzer:Dr. Florian Lüders/Florian Lüders

aus Wikipedia, der freien Enzyklopädie
Zur Navigation springen Zur Suche springen

Florian Lüders (* 25. November 1975 in Hildesheim, Deutschland) ist ein deutscher Internist, Angiologe, Lymphologe, Notfallmediziner, Ernährungsmediziner, mit Schwerpunkt regenerative physikalische Medizin, Mikroperfusionsstörungen, lymphatische Krankheitsbilder, perfusorische nichtinvasive Bildgebung (hyperspectral imaging).  

Publikationen

[Bearbeiten | Quelltext bearbeiten]
  • Lüders F. Statement: Versorgungsstrukturen hindern Leistungsqualität Rechtsdepeche RDG 2020,17(4)-Jul/Aug:221
  • Lüders F, Intramyocellular lipids Part I: Endurance: intramuscular fat accumulation and high-fat diet - how does this fit together?, Microcirculation and Lymphology- sports medicine 1 No 1 (2020)
  • Lüders F, Lymph and functional integrity – prologue, Microcirculation and Lymphology 1 No 1 (2019) DOI 10.2511/mcly.v1i1.3
  • Lüders F, Kaier K, Kaleschke G, Gebauer K, Meyborg M, Malyar NM, Freisinger E, Baumgartner E, Reinecke H, Reinöhl J, Association of chronic kidney disease with outcomes among patients undergoing transcatheter aortic valve implantation, accepted 02/2017, Clinical Journal of the American Society of Nephrology [CJASN] · 4.7 Impact Factor
  • Skonetzki S *, Lüders F *, Engelbertz Ch, Malyar N, Freisinger E, Meyborg M, Reinecke H, Aging and outcome in patients with peripheral artery disease and critical limb ischemia. Journal of the American Medical Directors Association [JAMDA], 06/2016 · 6.616 Impact Factor
    • The first two authors contributed equally to this work.
  • Lüders F, Fürstenberg T, Engelbertz Ch, Gebauer K, Meyborg M, Malyar N, Reinecke H, The Impact of Chronic Kidney Disease on Hospitalized Patients With Peripheral Arterial Disease and Critical Limb Ischemia, Angiology, 04/2016, DOI: 10.1177/0003319716638797 · 2.931 Impact Factor
  • Lüders F, Engelbertz Ch, Meyborg M, Freisinger E, Malyar N , Zeller T, Reinecke H, Acute and chronic anemia and short- and long-term outcome of patients with peripheral arterial disease and critical limb ischemia, European Journal of Internal Medicine, 03/2016, DOI:10.1016/j.ejim.2016.03.002 · 2.591 Impact Factor
  • Lüders F, Bunzemeier H, Engelbertz Ch, Malyar N, Meyborg M, Roeder H, Berger K, Reinecke H, CKD and Acute and Long-Term Outcome of Patients with Peripheral Artery Disease and Critical Limb Ischemia, Clinical Journal of the American Society of Nephrology [CJASN], 12/2015, DOI:10.2215/CJN.05600515 · 5.061 Impact Factor
  • Lüders F, Malyar N, Meyborg M, Reinecke H, The preinterventional Cystatin-Creatinine-ratio: a prognostic marker for contrast medium-induced acute kidney injury and long-term all-cause mortality, Nephron, 08/2015; DOI:10.1159/000438755 · 13.26 Impact Factor
  • Lüders F, Reinecke H, Gefäßerkrankungen und -komplikationen im Rahmen von Herzoperationen, Zeitschrift für Herz- Thorax- und Gefäßchirurgie 06/2015; 6(29):29. DOI:10.1007/s00398-015-0006-9
  • Lüders F, Doku A, Malyar NM, Reinecke H. Endovascular Management of a Periinterventional Crural Pseudoaneurysm – A Case Report and Review of Literature. International Journal of Case Reports in Medicine, DOI: 10.5171/2014.232740.
  • Lüders F, Malyar NM, Reinecke H. Preinterventional Cystatin C: A Highly Prognostic Marker for All-Cause Mortality after Coronarography, Advances in Nephrology, 09/2014; 2014. DOI:10.1155/2014/510209
  • Lüders F, Doku A, Malyar N, Reinecke H (2014) Endovascular Recanalization and Angioplasty of a Lengthy, 25 Years Old Superficial Femoral Artery Occlusion. J Cardiovasc Med Cardiol 1(1): 023-025.
  • Lüders F, Malyar N, Meyborg M, Gebauer K, Brand E, Reinecke H. Impact of peripheral arterial occlusive disease on the development of contrast medium-induced acute kidney injury. Nephron Clinical Practice, 03/2013; 122(1-2):38-43. DOI:10.1159/000346105 · 1.652 Impact Factor
  • Lüders F, Fischbach R , Seifarth H, Weßling J , Heindel W , Juergens KU. Dual-Source Computed Tomography: Effect on Regional and Global Left Ventricular Function Assessment Compared to Magnetic Resonance Imaging RöFo - Fortschritte auf dem Gebiet der R, 07/2009; 181(10):962-9. DOI:10.1055/s-0028-1109428 · 2.025 Impact Factor
  • Lüders F. Chronic kidney disease and atrial fibrillation: data from the German Competence Network Atrial Fibrillation, NephroNews, edition 6/15, 2015
  • Lüders F. Claudication - an underestimated public health problem. Heartjournal, Heartcentre Münster e.V.
  • Reinecke H, Unrath M, Freisinger E, Bunzemeier H, Meyborg M, Lüders F, Gebauer K, Roeder N, Berger K, Malyar NM. Peripheral arterial disease and critical limb ischaemia: still poor outcomes and lack of guideline adherence., European Heart Journal 02/2015; 36(15). DOI:10.1093/eurheartj/ehv006 · 15.20 Impact Factor
  • Malyar N, Kaier K, Freisinger E, Lüders F, Kaleschke G, Baumgartner H, Frankenstein L, Reinecke H, Reinöhl J. Prevalence and Impact of Critical Limb Ischemia on In-Hospital Outcome in Transcatheter Aortic Valve Implantation in Germany. EuroIntervention. 2017 Dec 20;13(11):1281-1287· 5.165 Impact Factor
  • Malyar N, Fürstenberg T, Wellmann J, Meyborg M, Lüders F, Gebauer K, Bunzemeier H, Roeder N, Reinecke H. Recent trends in morbidity and in-hospital outcomes of in-patients with peripheral arterial disease: a nationwide population-based analysis. European Heart Journal 07/2013; 34(34). DOI:10.1093/eurheartj/eht288 · 15.20 Impact Factor
  • Malyar NM, Freisinger E, Meyborg M, Lüders F, Gebauer K, Reinecke H, Lawall H. Amputations and mortality in in-hospital treated patients with peripheral artery disease and diabetic foot syndrome. J Diabetes Complications. 2016 Apr 4. pii: S1056-8727(16)30089-7. doi: 10.1016/j.jdiacomp.2016.03.033 · 3.01 Impact Factor
  • Malyar NM, Freisinger E, Meyborg M, Lüders F, Fürstenberg T, Kröger K, Torsello G, Reinecke H. Low Rates of Revascularization and High In-Hospital Mortality in Patients With Ischemic Lower Limb Amputation: Morbidity and Mortality of Ischemic Amputation. Angiology. 2016 Jan 13. pii: 0003319715626849· 2.97 Impact Factor
  • Stalling P, Engelbertz C, Lüders F, Meyborg M, Gebauer K, Waltenberger J, Reinecke H, Freisinger E, Unmet medical needs in Intermittent Claudicantion with Diabetes and Coronary Artery Disease - a 'real-world' analysis on 21,197 PAD patients, Clin Cardiol. 2019 Jun;42(6):629-636. doi: 10.1002/clc.23186. Epub 2019 May 6.
  • Richter L, Freisinger E, Lüders F, Gebauer K, Meyborg M, Malyar NM. Impact of diabetes type on treatment and outcome of patients with peripheral artery disease. Diab Vasc Dis Res. 2018 Sep 24 doi: 10.1177/1479164118793986
  • Meyborg M, Abdi-Tabari Z, Hoffmeier A, Engelbertz C, Lüders F, Freisinger E, Malyar NM, Martens S, Reinecke H. Outcome of patients with reduced ankle brachial index undergoing open heart surgery with cardiopulmonary bypass. Journal of Cardiothoracic Surgery 10/2015; DOI:10.1093/ejcts/ezv376
  • Meyborg M, Engelbertz C, Lüders F, Gebauer K, Malyar NM, Reinecke H. Acute and mid-term outcomes after treatment of multiple, recurrent restenoses of the lower limb. International angiology: a journal of the International Union of Angiology 07/2014; 34(3). · 0.83 Impact Factor
  • Gebauer K, Engelbertz CM, Malyar N, Meyborg M, Lüders F, Freisinger E, Reinecke H. Long-Term Mortality After Invasive Angiography and Endovascular Revascularization in Patients With PAD Having Chronic Kidney Disease. Angiology. August 2015; DOI:10.1177/0003319715603184 · 2.97 Impact Factor
  • Weber K, Gebauer K, Lüders F, Meyborg M, Malyar NM, Reinecke H. Micro-lightguide spectrophotometry (O2C®) as a predictor of intermediate outcome in patients with critical limb ischemia after percutaneous transluminal angioplasty (PTA). International angiology: a journal of the International Union of Angiology 05/2014; 33(6). · 0.83 Impact Factor
  • Lebiedz P, Knickel L, Engelbertz C, Lüders F, Gebauer K, Berdel WE, Waltenberger J, Reinecke H. Impact of preexisting chronic kidney disease on acute and long-term outcome of critically ill patients on a medical intensive care unit. Journal of nephrology 02/2013; 27(1). DOI:10.1007/s40620-013-0016-1 · 1.45 Impact Factor


reviewer for

[Bearbeiten | Quelltext bearbeiten]
  • Stroke (impact factor)
  • Perfusion (impact factor)
  • Annals of Internal Medicine (impact factor)
  • PLOS ONE (impact factor)
  • Medicine (impact factor)
  • Nephrology (impact factor)


member of editorial board

[Bearbeiten | Quelltext bearbeiten]
  • Journal of Heart and Circulation
  • Mathews Journal of Emergency Medicine
  • Journal of Physical Rehabilitation Medicine
  • Microcirculation and Lymphology


sub- / investigator of

[Bearbeiten | Quelltext bearbeiten]
  • FREERIDE (ClinicalTrials.gov Identifier: NCT01960647)
  • ALECARDIO (ClinicalTrials.gov Identifier: NCT01042769)
  • LEVANT2 Registry (ClinicalTrials.gov Identifier: NCT01628159)
  • BIOFLEX-I Europe (ClinicalTrials.gov Identifier: NCT01661231)
  • CL0017-01 (Long Lesion) (ClinicalTrials.gov Identifier: NCT02013271)
  • Carima-Study (ClinicalTrials.gov Identifier: NCT02559622)
  • Lutonix (BTK) (ClinicalTrials.gov Identifier: NCT01870401)
  • Pluristem PLX-PAD(ClinicalTrials.gov Identifier: NCT01679990)


awards

[Bearbeiten | Quelltext bearbeiten]
  • 16th tri-country congress in 2013, Graz, Austria, Best Poster award

"The preinterventinal cystatin-Creatinine ratio: a prognostic marker for contrast medium induced acute kidney injury and long-term all-cause mortality" [pub.: Lüders F, Malyar N, Meyborg M, Reinecke H, The preinterventional Cystatin-Creatinine-ratio: a prognostic marker for contrast medium-induced acute kidney injury and long-term all-cause mortality, Nephron, 08/2015; DOI:10.1159/000438755]


abstracts

[Bearbeiten | Quelltext bearbeiten]
  • Lüders F, Herrera R, Kacik M, Hyperspectral evaluation of efficiency of decongestive therapy for lymphedema: the L-ratio, Vol 1 No 1 (2019): Microcirculation and Lymphology DOI:10.2511/mcly.v1i1
  • Preinterventional cystatin C level - a highly prognostic marker? Vasa 2012; 41, Suppl.82: P2.6.
  • Impact of peripheral arterial occlusive disease on the development of contrast medium-induced acute kidney injury. Vasa 2012; 41, Suppl.82: P4.6.
  • The influence of CKD on morbidity, outcomes and health care costs of Patients with Peripheral Arterial Disease in Germany from 2005 to 2009. Vasa 2013; 42, Suppl.84: PP1.2.
  • The preinterventinal cystatin-Creatinine ratio: a prognostic marker for contrast medium induced acute kidney injury and long-term all-cause mortality. Vasa 2013; 42, Suppl.84: PP3.5.
  • The Impact of Chronic Kidney Disease on In-Hospital Mortality, Amputations and Costs of Patients with Peripheral Arterial Disease in Germany 2009. Vasa 2014; 43, Suppl.86: FV7.2.
  • Impact of acute and chronic anemia on morbidity, short- and long-term outcome of patients with peripheral arterial disease. Vasa 2014; 43, Suppl.86: P 1.07.
  • Impact of chronic kidney disease on acute and long-term outcome of patients with peripheral artery disease and critical limb ischemia. Vasa 2014; 43, Suppl.86: P 3.01.
  • Impact of chronic kidney disease on outcome of patients after transcatheter aortic valve implantation – insights from nationwide German data of the years 2010-2013, DGA 2016, dann VASA
  • Morbidity and In-hospital Outcomes of Patients with Peripheral Arterial Disease According to Fontaine Classes in Germany from 2005 to 2009. Vasa 2012; 41, Suppl.82.
  • Langzeitverlauf von Patienten mit rezidivierenden In-Stent-Stenosen der Becken-und Oberschenkelarterien. Vasa 2012; 41, Suppl.82.
  • Longterm mortality after percutanous transluminal angioplasty in PAD patients with chronic kidney disease. Jahrestagung der Dt. Gesellschaft für Angiologie, Graz 2013.
  • Recent Trends in Morbidity and In-hospital Outcomes of Inpatients with Peripheral Arterial Disease – a Nationwide Population-Based Analysis. Jahrestagung der Dt. Gesellschaft für Angiologie, Graz 2013.
  • Gender Related Disparity in Hospitalization and In-Hospital Outcome of Patients with Peripheral Arterial Disease. Jahrestagung der Dt. Gesellschaft für Angiologie, Graz 2013.
  • Outcome of Patients with reduced ankle brachial index (ABI) under-going open heart surgery with cardiopulmonary bypass. Jahrestagung der Dt. Gesellschaft für Angiologie, Graz 2013.
  • Peripheral Arterial Disease Increases In-hospital Mortality in Patients with Acute Myocardial Infarction - a Nationwide Population-based Analysis. Jahrestagung der Dt. Gesellschaft für Angiologie, Graz 2013
  • A contemporary analysis of the long-term prognosis of patients with peripheral arterial disease. VASA 2014;43 (Supplement):41-42.
  • Impact of Revascularization on Survival in Patients with Tissue Loss due to Critical Limb Ischemia. DGA Abstract FV4.3.
  • The Impact of Gender on Therapy and Outcome of Peripheral Artery Disease. DGA Abstract FV4.1.
  • Acute and mid-term outcomes after treatment of multiple, recurrent lower limb arteries of the restenoses, Vasa 2013, Suppl
  • Peripheral Arterial Disease Increases In-hospital Mortality in Patients with Acute Myocardial Infarction - A Nationwide Population-based Analysis , Vasa 2013, Suppl.
  • Incidence of Lower Extremity Amputation due to Acute and Chronic Limb Ischemia in Germany From 2002-2008, Vasa 2014, Suppl.
  • Longterm mortality after invasive diagnostic and endovascular revascularization in PAD patients with chronic kidney disease, abstract 80 th Annual Meeting of the German Cardiac Society (Deutsche Gelsellschaft für Kardiologie "dgk"), april 2014


broadcast reports

[Bearbeiten | Quelltext bearbeiten]
  • WomensHealth, Linda Babst, Lipödem: Das können Sie dagegen tun! 14.02.2019
  • Florian Lüders im WDR1 Interview 17.07.2018


[Bearbeiten | Quelltext bearbeiten]
Personendaten
NAME Lüders, Florian
KURZBESCHREIBUNG deutscher Internist, Angiologe, Lymphologe, Notfallmediziner, Ernährungsmediziner
GEBURTSDATUM 25. November 1975
GEBURTSORT Hildesheim, Deutschland
Abgerufen von „https://de.wikipedia.org/w/index.php?title=Benutzer:Dr._Florian_Lüders/Florian_Lüders&oldid=206300685“